Ind-Swift Laboratories has posted poor financial performance during the fourth quarter ended March 2015 and its standalone net loss amounted to Rs. 70.91 as against Rs. 92.73 crore in the corresponding period of last year. Though its net loss ... PharmaBiz, 3 days ago
Ind-Swift Laboratories reports standalone net loss of Rs 70.91 crore in the March 2015 quarter - Business Standard, 4 days ago
Conquer Investments sells 2.6 lakh shares of Ind-Swift Labs - Money Control, 2 weeks ago
J&K Bank, Corporation Bank, Ind-Swift Laboratories, Ashima, Rattan India Infrastructure, JK Paper, GVK Power, Godawari Power and Ispat, MIC Electronics, Nagarjuna Oil Refinery, IFGL Refractories, Astec Lifesciences, Orient Abrasives, Ramkrishna ...Hindu Business Line, 1 week ago
The pledging of shares by promoters of the NSE-listed companies have increased nearly 30 per cent in 2014-15. According to a report from Prime Database, the value of pledged shares moved up to Rs 1.94 lakh crore against Rs 1.52 lakh crore in the ...Business Standard India, 2 weeks ago
The overall financial performance of Indian pharmaceutical industry may be under pressure in the current year 2014-15 due to new Drug Price Control Order and quality problems raised by US FDA. The growth in sales as well as profits before ...PharmaBiz, 1 month ago
on your WebpageAdd Widget >Get your members hooked!